Saluda Medical Evoke SCS System
FDA premarket approval P190002/S011 · decided 2022-08-09
Approval details
- PMA number
- P190002
- Supplement
- S011
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- Saluda Medical Evoke SCS System
- Generic name
- Stimulator, spinal-cord, totally implanted for pain relief
- Applicant
- Saluda Medical Pty, Ltd.
- Date received
- 2022-05-11
- Decision date
- 2022-08-09
- Days to decision
- 90 days
- Decision code
- APPR
- Product code
- LGW
- Advisory committee
- Neurology
- Expedited review
- No
- Location
- Atarmon
- Statement
- Approval for alternate Surface Pro tablet models, SP6 and SP7+, to be used for the Clinical Interface due to obsolescence of previous models.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.